Clinical Trial Update: Safety and Efficacy of BMMNCin Patients With Mental Retardation [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 clinical trial evaluating the safety and efficacy of bone marrow mononuclear cells in patients with intellectual disability. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intellectual Disability

Drugs mentioned

• Bone marrow mononuclear cells (BMMNC) (bone marrow mononuclear cells)

Snippet

Sponsor: Chaitanya Hospital, Pune | Conditions: Mental Retardation | Phase 1, Phase 2 | Status: UNKNOWN